CFL2 and myopathy: The mutation converts Ala-35 into Thr and significantly reduces the cofilin-2 protein level in skeletal muscle and impairs solubility when recombinant cofilin-2 is expressed in a bacterial system, suggesting that the myopathy-causing mutation is a loss-of-function mutation.